Brain Stimulation for Dyslexia
Trial Summary
What is the purpose of this trial?
The goal of this project is to address the urgent need for effective, scalable adult literacy interventions by integrating breakthroughs in two separate fields: 1.) the brain network science of resilience to reading disorders and 2.) high-definition non-invasive brain network stimulation. This study will first establish the efficacy of a novel, noninvasive stimulation protocol on reading behavior and brain metrics; then will determine how stimulation-induced effects interact with baseline reading comprehension ability; and lastly, will identify whether stimulation-induced effects are more clinically-beneficial than canonical behavioral interventions. Results may change the foundation for how we treat low adult literacy, and have the potential for wider reaching impacts on non-invasive stimulation protocols for other clinical disorders.
Will I have to stop taking my current medications?
The trial excludes participants who are taking psychotropic medications or medications known to increase the risk of seizures or strokes. If you are on such medications, you may need to stop taking them to participate.
What data supports the effectiveness of this treatment for dyslexia?
Research shows that transcranial direct current stimulation (tDCS), a part of the treatment, has been used to help with motor disabilities and depression by influencing brain activity. This suggests it might also help with dyslexia by potentially improving brain function related to reading and language skills.12345
Is brain stimulation for dyslexia safe for humans?
Transcranial electrical stimulation (TES), including transcranial direct current stimulation (tDCS), is generally considered safe in humans, with no serious adverse events reported in over 18,000 sessions. Mild side effects like headaches and skin sensations are common, but serious issues are rare.678910
How does the brain stimulation treatment for dyslexia differ from other treatments?
This treatment uses non-invasive brain stimulation, specifically transcranial direct current stimulation (tDCS), to enhance reading abilities by targeting underactive brain areas involved in reading. Unlike other treatments, it shows promise in providing long-lasting improvements in reading skills for individuals with dyslexia, especially when combined with reading training.1112131415
Research Team
Katherine S. Aboud, PhD
Principal Investigator
Vanderbilt University
Eligibility Criteria
This trial is for right-handed, native English-speaking adults aged 18-40 with dyslexia. Participants must not have a low IQ, developmental disorders, visual or hearing impairments that can't be corrected, metal devices in their body, recent migraines, severe fatigue or psychiatric issues. They should not be pregnant and mustn't take certain medications.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Establish baseline behavior and brain measures of the individual
Intervention
Behavioral and non-invasive stimulation intervention, including MRI and EEG sessions
Follow-up Assessment
Establish prolonged intervention effects using behavior and brain measures
Long-term Follow-up
Participants are monitored for changes in reading comprehension and brain activations
Treatment Details
Interventions
- CCN real non-invasive brain stimulation intervention
- RLN and CCN real non-invasive brain stimulation intervention
- RLN real non-invasive brain stimulation intervention
- Sham intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator